Bone Biologics | 8-K: Current report
Mar 15 16:52 ET
Bone Biologics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mitchell P. Kopin(9.99%),Daniel B. Asher(9.99%), etc.
Mar 14 17:15 ET
Bone Biologics | 8-K: Current report
Mar 6 16:28 ET
Bone Biologics | EFFECT: Others
Mar 5 06:07 ET
Bone Biologics | 424B4: Prospectus
Mar 4 17:48 ET
Bone Biologics | CORRESP: CORRESP
Mar 1 12:38 ET
Bone Biologics | 8-K: Current report
Mar 1 08:09 ET
Bone Biologics | CORRESP: CORRESP
Feb 29 12:38 ET
Bone Biologics | CORRESP: CORRESP
Feb 28 12:38 ET
Bone Biologics | CORRESP: CORRESP
Feb 27 12:38 ET
Bone Biologics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Feb 26 16:57 ET
Bone Biologics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Feb 23 17:16 ET
Bone Biologics | 10-K: Annual report
Feb 21 17:12 ET
Bone Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ionic Ventures, LLC(6.5%),Ionic Management, LLC(6.5%), etc.
Feb 14 18:43 ET
Bone Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Walleye Capital LLC(0.0%)
Feb 14 10:57 ET
Bone Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(6.0%),Lind Global Partners II LLC(6.0%), etc.
Feb 13 20:06 ET
Bone Biologics | UPLOAD: Others
Feb 5 12:38 ET
Bone Biologics | S-1: General form for registration of securities under the Securities Act of 1933
Jan 30 17:13 ET
Bone Biologics | EFFECT: Others
Jan 25 06:05 ET
Bone Biologics | CORRESP: CORRESP
Jan 22 22:16 ET
No Data
No Data